Marchand Kevin B, Vakharia Rushabh, Sodhi Nipun, Anis Hiba, Salem Hytham S, Scuderi Giles R, Mont Michael A, Roche Martin William
Northwell Health Orthopedics, Lenox Hill Hospital, New York, New York.
Department of Orthopedic Surgery, Holy Cross Hospital, Trinity Health, Fort Lauderdale, Florida.
J Knee Surg. 2022 Jan;35(1):21-25. doi: 10.1055/s-0040-1710546. Epub 2020 May 27.
Large-scale studies evaluating the effects of Parkinson's disease (PD) on primary total knee arthroplasty (TKA) are limited. The purpose of this study was to determine if PD patients undergoing primary TKA have increased: (1) medical complications; (2) implant-related complications; (3) readmission rates; and (4) costs. A query was performed using an administrative claims database. The study group consisted of all patients undergoing primary TKA who had a history of PD. Matched non-PD patients undergoing primary TKA served as a control group. The query yielded 72,326 patients (PD = 18,082; matching cohort = 54,244). Pearson's chi-square tests, logistic regression analyses, and Welch's tests were used to test for significance between the cohorts. Primary TKA patients who had PD were found to have greater incidences and odds of medical complications (4.21 vs. 1.24%; odds ratio [OR]: 3.50, 95% confidence interval [CI]: 3.15-3.89, 0.0001) and implant-related complications (5.09 vs. 3.15%; OR: 1.64, 95% CI: 1.51-1.79, 0.0001) compared with the matching cohort. Additionally, the rates and odds of 90-day readmission were higher (16.29 vs. 12.66%; OR:1.34, 0.0001) and episodes of care costs were significantly greater ($17,105.43 vs. $15,252.34, 0.0001) in patients who had PD. Results demonstrate that PD patients undergoing primary TKA had higher incidences of medical and implant-related complications. They also had increased 90-day readmission rates and costs compared with controls. The findings of this study should be used in risk stratification and should inform physician-patient discussion but should not be arbitrarily used to deny access to care.
评估帕金森病(PD)对初次全膝关节置换术(TKA)影响的大规模研究有限。本研究的目的是确定接受初次TKA的PD患者是否增加了:(1)医疗并发症;(2)植入物相关并发症;(3)再入院率;以及(4)费用。使用行政索赔数据库进行了查询。研究组由所有有PD病史且接受初次TKA的患者组成。匹配的接受初次TKA的非PD患者作为对照组。该查询产生了72326名患者(PD组=18082名;匹配队列=54244名)。使用Pearson卡方检验、逻辑回归分析和Welch检验来检验队列之间的显著性。发现与匹配队列相比,患有PD的初次TKA患者发生医疗并发症的发生率和几率更高(4.21%对1.24%;优势比[OR]:3.50,95%置信区间[CI]:3.15 - 3.89,P = 0.0001)以及植入物相关并发症(5.09%对3.15%;OR:1.64,95% CI:1.51 - 1.79,P = 0.0001)。此外,PD患者90天再入院率和几率更高(16.29%对12.66%;OR:1.34,P = 0.0001),护理费用也显著更高(17105.43美元对15252.34美元,P = 0.0001)。结果表明,接受初次TKA的PD患者发生医疗和植入物相关并发症的发生率更高。与对照组相比,他们的90天再入院率和费用也有所增加。本研究的结果应用于风险分层,并为医患讨论提供参考,但不应被随意用于拒绝患者获得治疗的机会。